- Report
- October 2024
- 192 Pages
Global
From €3248EUR$3,545USD£2,760GBP
€3608EUR$3,939USD£3,067GBP
- Report
- February 2025
- 200 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Report
- April 2025
- 147 Pages
Global
From €2747EUR$2,999USD£2,335GBP
- Report
- September 2024
- 142 Pages
Global
From €2747EUR$2,999USD£2,335GBP
- Report
- June 2024
- 150 Pages
Global
From €5451EUR$5,950USD£4,632GBP
- Report
- May 2025
- 281 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 467 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 277 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 370 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 478 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 277 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3435EUR$3,750USD£2,920GBP
- Report
- July 2024
- 150 Pages
Global
From €3435EUR$3,750USD£2,920GBP
- Report
- July 2024
- 100 Pages
Global
From €3435EUR$3,750USD£2,920GBP
- Report
- June 2024
- 200 Pages
Global
From €7283EUR$7,950USD£6,190GBP
- Report
- June 2024
- 200 Pages
Global
From €7283EUR$7,950USD£6,190GBP
- Report
- June 2024
- 200 Pages
Global
From €7283EUR$7,950USD£6,190GBP
- Report
- April 2025
- 114 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- March 2025
- 150 Pages
Global
From €4443EUR$4,850USD£3,776GBP

The Dry Eye Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Dry Eye Drugs are used to treat the symptoms of dry eye syndrome, a condition in which the eyes do not produce enough tears or the tears evaporate too quickly. These drugs can be administered topically, orally, or through injection. Commonly used Dry Eye Drugs include artificial tears, anti-inflammatory medications, and immunomodulators.
Some companies in the Dry Eye Drug market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, Shire, and Sun Pharmaceuticals. Show Less Read more